References
- LipinskiCALombardoFDominyBWFeeneyPJExperimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdv Drug Deliv Rev20014632611259830
- SinghSParikhTSandhuHKSupersolubilization and amorphization of a model basic drug, haloperidol, by interaction with weak acidsPharm Res2013301561157323430485
- BroughCWilliamsROAmorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug deliveryInt J Pharm201345315716623751341
- KawabataYWadaKNakataniMYamadaSOnoueSFormulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applicationsInt J Pharm201142011021884771
- MüllerRHJacobsCKayserONanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the futureAdv Drug Deliv Rev20114731911251242
- Merisko-LiversidgeELiversidgeGGNanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technologyAdv Drug Deliv Rev20116342744021223990
- VasconcelosTSarmentoBCostaPSolid dispersions as strategy to improve oral bioavailability of poor water soluble drugsDrug Discov Today2007121068107518061887
- ThomasMJSlipperIWalunjAInclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticlesInt J Pharm201038727227720025947
- WangSOrdered mesoporous materials for drug deliveryMicroporous Mesoporous Mater200911719
- KuangDBrezesinskiTSmarslyBHierarchical porous silica materials with a trimodal pore system using surfactant templatesJ Am Chem Soc2004126105341053515327299
- WaniAMuthuswamyESavithraGHMaoGBrockSOupickýDSurface functionalization of mesoporous silica nanoparticles controls loading and release behavior of mitoxantronePharm Res2012292407241822555380
- ZhangYWangJBaiXJiangTZhangQWangSMesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugsMol Pharm2012950551322217205
- KinnariPMäkiläEHeikkiläTSalonenJHirvonenJSantosHAComparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazoleInt J Pharm201141414815621601623
- ParakhonskiyBVHaaseAAntoliniRSub-micrometer vaterite containers: synthesis, substance loading, and releaseAngew Chem Int Ed Engl2012511195119722375283
- PreisigDHaidDVarumFJDrug loading into porous calcium carbonate microparticles by solvent evaporationEur J Pharm Biopharm20148754855824568926
- SvenskayaYParakhonskiyBHaaseAAnticancer drug delivery system based on calcium carbonate particles loaded with a photosensitizerBiophys Chem2013182111523932207
- KurapatiaRRaichurAMComposite cyclodextrin–calcium carbonate porous microparticles and modified multilayer capsules: novel carriers for encapsulation of hydrophobic drugsJ Mater Chem B2013131753184
- Kassler-TaubKLittlejohnTElliottWRuddyTAdlerEComparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study InvestigatorsAm J Hypertens1998114454539607383
- FaresMMSalemMSKhanfarMInulin and poly(acrylic acid) grafted inulin for dissolution enhancement and preliminary controlled release of poorly water-soluble Irbesartan drugInt J Pharm201141020621121421037
- StevensWJLebeauKMertensMVan TendelooGCoolPVansantEFInvestigation of the morphology of the mesoporous SBA-16 and SBA-15 materialsJ Phys Chem B20061109183918716671732
- HiguchiTConnorsKAPhase-solubility techniquesAdv Anal Chem Instrum19654117212
- KrukMAccess to ultralarge-pore ordered mesoporous materials through selection of surfactant/swelling-agent micellar templatesAcc Chem Res2012451678168722931347
- ShenSCNgWKChiaLHuJTanRBPhysical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle sizeInt J Pharm201141018819521419202
- GuoZLiuXMMaLEffects of particle morphology, pore size and surface coating of mesoporous silica on naproxen dissolution rate enhancementColloids Surf B Biointerfaces201310122823523010024
- ZhangPForsgrenJStrømmeMStabilisation of amorphous ibuprofen in Upsalite, a mesoporous magnesium carbonate, as an approach to increasing the aqueous solubility of poorly soluble drugsInt J Pharm201447218519124950364
- JacksonCLMcKennaGBVitrification and crystallization of organic liquids confined to nanoscale poresChem Mat1996821282137
- LiuMCaoWSunYHeZPreparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-b-cyclodextrinInt J Pharm201447715916625455768
- ZoellerTDressmanJBKleinSApplication of a ternary HP-β-CD-complex approach to improve the dissolution performance of a poorly soluble weak acid under biorelevant conditionsInt J Pharm201243017618322531855
- Vallet-RegiMBalasFArcosDMesoporous materials for drug deliveryAngew Chem Int Ed Engl2007467548755817854012
- Vallet-RegiMNanostructured mesoporous silica matrices in nanomedicineJ Intern Med2010267224320059642
- DokoumetzidisAMacherasPA century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification systemInt J Pharm200632111116920290